For: | Reiche W, Tauseef A, Sabri A, Mirza M, Cantu D, Silberstein P, Chandan S. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World J Transplant 2022; 12(8): 268-280 [PMID: 36159076 DOI: 10.5500/wjt.v12.i8.268] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v12/i8/268.htm |
Number | Citing Articles |
1 |
Agata Marjanska, Jan Styczynski. Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 2023; 23(6): 539 doi: 10.1080/14712598.2023.2196366
|
2 |
Timothy Dean Minniear, Surabhi Vora. How we treat diarrhea in pediatric transplant patients: a brief review. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1287445
|
3 |
Nour Hasan, Ramia Zakhour, Luz Helena Gutierrez Sanchez, Audrey R. Lloyd, Geling Li, Clara L. Ortiz, Cecelia Hutto. Post-Transplant Lymphoproliferative Disorder Presenting as a Gastrointestinal Fistulous Tract in a Heart Transplant Recipient: Case Report and Literature Review. Transplantation Proceedings 2024; doi: 10.1016/j.transproceed.2024.07.008
|